| P50 | author | Evan Dellon | Q87734596 |
| P2093 | author name string | Gary W Falk | |
| | Glenn T Furuta | |
| | Ting Wen | |
| | Lisa J Martin | |
| | Marc E Rothenberg | |
| | Guang-Yu Yang | |
| | Margaret H Collins | |
| | Jonathan M Spergel | |
| | John Leung | |
| | Julie M Caldwell | |
| | Seema S Aceves | |
| | Tetsuo Shoda | |
| | Paul Menard-Katcher | |
| | Julia L M Dunn | |
| | Joshua B Wechsler | |
| | Amanda Rudman-Spergel | |
| | CEGIR | |
| P2860 | cites work | A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. | Q45064623 |
| | Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children | Q47296828 |
| | Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens. | Q47732959 |
| | Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial | Q48509747 |
| | Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system | Q48636350 |
| | An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. | Q53226482 |
| | IL-4 induces IL-13-independent allergic airway inflammation. | Q53607041 |
| | Suppressive effect of IL-4 on IL-13-induced genes in mouse lung. | Q54671993 |
| | Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). | Q55020153 |
| | RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis | Q58616289 |
| | Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner | Q61959718 |
| | Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial | Q61959735 |
| | Allergic esophagitis in children: a clinicopathological entity | Q77311212 |
| | Treatment of eosinophilic esophagitis: diet, drugs, or dilation? | Q84030386 |
| | Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study | Q88578701 |
| | Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites | Q88934279 |
| | Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference | Q90229220 |
| | 17β-Estradiol protects the esophageal epithelium from IL-13-induced barrier dysfunction and remodeling | Q90714835 |
| | Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study | Q91323752 |
| | Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis | Q92928315 |
| | Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration | Q93212833 |
| | IL-4 and IL-13 signaling in allergic airway disease | Q26859510 |
| | Common variants at 5q22 associate with pediatric eosinophilic esophagitis | Q28943383 |
| | Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. | Q30234446 |
| | A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults | Q30844945 |
| | Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 |
| | IL-5 triggers a cooperative cytokine network that promotes eosinophil precursor maturation. | Q34289253 |
| | GWAS identifies four novel eosinophilic esophagitis loci | Q34545768 |
| | A single biopsy is valid for genetic diagnosis of eosinophilic esophagitis regardless of tissue preservation or location in the esophagus | Q36113811 |
| | A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease | Q36142507 |
| | Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells. | Q36243111 |
| | Anti-IL-5 attenuates activation and surface density of β(2) -integrins on circulating eosinophils after segmental antigen challenge. | Q36630280 |
| | LRRC31 is induced by IL-13 and regulates kallikrein expression and barrier function in the esophageal epithelium | Q36804012 |
| | Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia | Q37124757 |
| | Mepolizumab and exacerbations of refractory eosinophilic asthma | Q37711391 |
| | A striking local esophageal cytokine expression profile in eosinophilic esophagitis. | Q38338212 |
| | Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. | Q38707910 |
| | Genetics of eosinophilic esophagitis | Q39146390 |
| | Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring | Q40013081 |
| | Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment. | Q40961367 |
| | Clinical Applications of the Eosinophilic Esophagitis Diagnostic Panel | Q41010688 |
| | Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. | Q41163839 |
| | Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis | Q41307296 |
| | Synaptopodin is upregulated by IL-13 in eosinophilic esophagitis and regulates esophageal epithelial cell motility and barrier integrity. | Q42517074 |
| | IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway | Q42559693 |
| | Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis | Q45003326 |
| P921 | main subject | eosinophilic esophagitis | Q2057356 |
| P577 | publication date | 2020-03-17 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Esophageal type 2 cytokine expression heterogeneity in eosinophilic esophagitis in a multi-site cohort | |